TY - JOUR
T1 - Interactions of the extracellular matrix proteoglycans decorin and biglycan with C1q and collectins
AU - Groenevdd, Tom W.L.
AU - Oroszlán, Melinda
AU - Owens, Rick T.
AU - Faber-Krol, Maria C.
AU - Bakker, Astrid C.
AU - Asrlaud, Gérard J.
AU - McQuillan, David J.
AU - Kishore, Uday
AU - Daha, Mohamed R.
AU - Roos, Anja
PY - 2005/10/1
Y1 - 2005/10/1
N2 - Decorin and biglycan are closely related abundant extracellular matrix proteoglycans that have been shown to bind to C1q. Given the overall structural similarities between C1q and mannose-binding lectin (MBL), the two key recognition molecules of the classical and the lectin complement pathways, respectively, we have examined functional consequences of the interaction of C1q and MBL with decorin and biglycan. Recombinant forms of human decorin and biglycan bound C1q via both collagen and globular domains and inhibited the classical pathway. Decorin also bound C1 without activating complement. Furthermore, decorin and biglycan bound efficiently to MBL, but only biglycan could inhibit activation of the lectin pathway. Other members of the collectin family, including human surfactant protein D, bovine collectin-43, and conglutinin also showed binding to decorin and biglycan. Decoria and biglycan strongly inhibited C1q binding to human endothelial cells and U937 cells, and biglycan suppressed C1q-induceid MCP-1 and IL-8 production by human endothelial cells. In conclusion, decorin and biglycan act as inhibitors of activation of the complement cascade, cellular interactions, and proinflammatory cytokine production mediated by C1q. These two proteoglycans are likely to down-regulate proinflammatory efects mediated by C1q, and possibly also the coltectins, at the tissue level.
AB - Decorin and biglycan are closely related abundant extracellular matrix proteoglycans that have been shown to bind to C1q. Given the overall structural similarities between C1q and mannose-binding lectin (MBL), the two key recognition molecules of the classical and the lectin complement pathways, respectively, we have examined functional consequences of the interaction of C1q and MBL with decorin and biglycan. Recombinant forms of human decorin and biglycan bound C1q via both collagen and globular domains and inhibited the classical pathway. Decorin also bound C1 without activating complement. Furthermore, decorin and biglycan bound efficiently to MBL, but only biglycan could inhibit activation of the lectin pathway. Other members of the collectin family, including human surfactant protein D, bovine collectin-43, and conglutinin also showed binding to decorin and biglycan. Decoria and biglycan strongly inhibited C1q binding to human endothelial cells and U937 cells, and biglycan suppressed C1q-induceid MCP-1 and IL-8 production by human endothelial cells. In conclusion, decorin and biglycan act as inhibitors of activation of the complement cascade, cellular interactions, and proinflammatory cytokine production mediated by C1q. These two proteoglycans are likely to down-regulate proinflammatory efects mediated by C1q, and possibly also the coltectins, at the tissue level.
UR - http://www.scopus.com/inward/record.url?scp=25444512040&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=25444512040&partnerID=8YFLogxK
U2 - 10.4049/jimmunol.175.7.4715
DO - 10.4049/jimmunol.175.7.4715
M3 - Article
C2 - 16177119
AN - SCOPUS:25444512040
SN - 0022-1767
VL - 175
SP - 4715
EP - 4723
JO - Journal of Immunology
JF - Journal of Immunology
IS - 7
ER -